21159 ⎘
Medicinal preparations containing antigens or antibodies comprising antibodies
Binding molecule specific for LIF and use thereof
#6602MULTIVALENT REGULATORY T CELL MODULATORS
#6603SYNERGISTIC COMBINATIONS OF METHIONINE DEPLETION AGENTS AND IMMUNE CHECKPOINT MODULATORS
#6604ANTI-PD-1 ANTIBODIES AND USES THEREOF
#6605METHODS OF TREATING CERVICAL CANCER BY ADMINISTERING A PD-1 INHIBITOR
#6606Immunogenic arginase 2 polypeptides
#6607Oncolytic virus expressing PD-1 binding protein and application of oncolytic virus
#6608Anti-VEGF-PD1 bispecific antibody with novel structure and use thereof
#6609Bispecific antibody molecules binding to CD3 and EGFRvIII
#6610Use of semaphorin-4D binding molecules for the treatment of Rett syndrome
#6611DOSING REGIMEN OF ANTI-TIGIT ANTIBODY FOR TREATMENT OF CANCER
#6612Dosage Regimens of Lingo-1 Antagonists and Uses for Treatment of Demyelinating Disorders
#6613Anti-podoplanin antibody
#6614COMBINATION THERAPY FOR TREATMENT OF DISEASE
#6615ANTI-CLDN18.2 ANTIBODY AND USES THEREOF
#6616Formulation of tocilizumab and method for treating COVID-19 by inhalation
#6617TREATING VASCULAR DISEASE AND COMPLICATIONS THEREOF
#6618Antibodies that bind TGF-Alpha and Epiregulin for use in the treatment of pain
#6619HUMANIZED AND VARIANT TGF-BETA1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
#6620TGF-β1 specific antibodies and methods and uses thereof
#6621Antibodies that bind to pathological Tau species and uses thereof
#6622Antibodies binding to citrullinated histone 2A and/or 4
#6623HIGH AFFINITY ANTIBODIES TARGETING TAU PHOSPHORYLATED AT SERINE 413
#6624ANTI-APOE4 ANTIGEN-BINDING PROTEINS AND METHODS OF USE THEREOF
#6625Dosing regimen for treating influenza virus diseases
#6626Pan-ebola virus neutralizing human antibodies and methods of use therefor
#6627TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#6628D-domain containing polypeptides and uses thereof
#6629Combination therapy for treatment of thoracic cancer using Ad-REIC/Dkk-3 and a checkpoint inhibitor
#6630METHODS AND COMPOSITIONS FOR TARGETING T-CELL CANCERS
#6631Dosing parameters for CD47 targeting therapies to hematologic malignancies
#6632Checkpoint Inhibitor and Vaccine Combinations and Use of Same for Immunotherapy
#6633Stable antibody-drug conjugate, preparation method therefor, and use thereof
#6634D-domain containing polypeptides and uses thereof
#6635T CELLS FROM LYMPHATIC FLUID FOR DIAGNOSTIC AND THERAPEUTIC USE
#6636[6R]-MTHF - an efficient folate alternative in 5-fluorouracil based chemotherapy
#6637Gene mutations and copy number alterations of EGFR, KRAS and MET
#6638T CELL RECRUITING POLYPEPTIDES BASED ON TCR ALPHA/BETA REACTIVITY
#6639ENGINEERED IGA ANTIBODIES AND METHODS OF USE
#6640TISSUE PLASMINOGEN ACTIVATOR ANTIBODIES AND METHOD OF USE THEREOF
#6641Dosage Regimen for TFPI Antagonists
#6642HER-2 binding antibodies
#6643Anti-PSGL-1 antibodies and uses thereof
#6644TFR-SPECIFIC BINDING MOIETIES AND TRANSCYTOSIS METHOD TO SELECT VNARS THAT CROSS CELLULAR BARRIERS
#6645Antibodies targeting CD137 and methods of use thereof
#6646Antibodies, uses and methods
#6647METHODS AND COMPOSITIONS RELATING TO ANTI-CHI3L1 ANTIBODY REAGENTS FOR THE TREATMENT OF FIBROSIS
#6648Bispecific EGFR/c-Met antibodies
#6649Anti-Met fab-Fc for the treatment of a tumor and/or metastasis
#6650Preparation and use of anti-MET-and-RON bispecific antibody and antibody-drug conjugate thereof
#6651METHOD FOR PURIFYING ACTIVE POLYPEPTIDES OR IMMUNOCONJUGATES
#6652Anti-B7-H3 monoclonal antibody and use thereof in cell therapy
#6653DOSING
#6654Checkpoint blockade and microsatellite instability
#6655METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS
#6656Anti-Siglec-5 antibodies and methods of use thereof
#6657SP35 Antibodies And Uses Thereof
#6658HUMAN FCRN-BINDING MODIFIED ANTIBODIES AND METHODS OF USE
#6659Methods of inhibiting complement factor H (CFH) comprising administering an antibody that binds CFH
#6660Subcutaneous dosage and administration of anti-C5 antibodies for treatment of paroxysmal nocturnal hemoglobinuria (PNH)
#6661ANTI-TAU CONSTRUCTS
#6662Composition for the treatment of antibody deficiencies
#6663GROWTH FACTOR ANTAGONISTS FOR ORGAN TRANSPLANT ALLOIMMUNITY AND ARTERIOSCLEROSIS
#6664Colon and Pancreas Cancer Peptidomimetics
#6665AXL-SPECIFIC ANTIBODIES FOR TREATMENT OF NON-SMALL CELL LUNG CANCER
#6666STABLE PREPARATION COMPRISING ANTI-PCSK9 ANTIBODY
#6667Compositions and methods of treating sarcoma lung metastasis
#6668Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers
#6669FGL2 NEUTRALING CELL THERAPY AND METHODS OF USE THEREOF
#6670METHODS FOR TREATMENT USING CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR B-CELL MATURATION ANTIGEN
#6671CHIMERIC ANTIGEN RECEPTORS SPECIFIC FOR G PROTEIN-COUPLED RECEPTOR CLASS C GROUP 5 MEMBER D (GPRC5D)
#6672THERAPY FOR METASTATIC UROTHELIAL CANCER WITH THE ANTIBODY-DRUG CONJUGATE, SACITUZUMAB GOVITECAN (IMMU-132)
#6673Adeno-associated virus (AAV) delivery of anti-FAM19A5 antibodies
#6674Gene-regulating compositions and methods for improved immunotherapy
#6675PROTEASE CLEAVABLE BISPECIFIC ANTIBODIES AND USES THEREOF
#6676COMPOSITIONS AND METHODS FOR DIAGNOSIS OF CARDIOVASCULAR DISEASE
#6677Procoagulant antibodies
#6678Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer
#6679Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same
#6680CELL INJURY INDUCING THERAPEUTIC DRUG FOR USE IN CANCER THERAPY
#6681COMPOSITIONS AND METHODS REGARDING ENGINEERED AND NON-ENGINEERED GAMMA DELTA T-CELLS FOR TREATMENT OF SOLID TUMORS
#6682Anti-CD39 antibodies
#6683METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS AND PERICYTE COMPOSITION
#6684SUBCUTANEOUS ADMINISTRATION OF ANTI-CD38 ANTIBODIES
#6685COMPOSITIONS AND METHODS REGARDING ENGINEERED AND NON-ENGINEERED GAMMA DELTA T-CELLS FOR TREATMENT OF HEMATOLOGICAL TUMORS
#6686METHOD FOR TREATING MULTIPLE SCLEROSIS
#6687ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)
#6688NK engager molecules and methods of use thereof
#6689METHOD OF TREATING PRIMARY SCLEROSING CHOLANGITIS
#6690ANTIGEN BINDING AGENTS THAT BIND CD277 AND USES THEREOF
#6691Chimeric protein comprising an interferon alpha 2mutant and a PD-L1 binding moiety
#6692ANTIGEN-BINDING MOLECULES CAPABLE OF BINDING CD3 AND CD137 BUT NOT SIMULTANEOUSLY
#6693Anti-CD79b antibodies, drug conjugates, and applications thereof
#6694TARGETING CONSTRUCTS BASED ON NATURAL ANTIBODIES AND USES THEREOF
#6695ANTI-EMAP II ANTIBODY AND USE THEREOF
#6696Use of CXCL13 binding molecules to promote peripheral nerve regeneration
#6697Antibodies and uses thereof
#6698ANTIBODIES AGAINST HUMAN ANGIOPOIETIN 2
#6699CO-ADMINISTRATION OF A HYALURONIDASE AND ANTI-C5 ANTIBODY FOR TREATMENT OF COMPLEMENT-ASSOCIATED CONDITIONS
#6700METHODS AND COMPOSITIONS FOR REGULATING IRON HOMEOSTASIS BY MODULATION OF BMP-6
#6701Anti-CfaE antibodies and methods of use
#6702Anti-coronavirus antibodies and methods of use
#6703TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#6704TECHNIQUES FOR PREDICTING, DETECTING AND REDUCING ASPECIFIC PROTEIN INTERFERENCE IN ASSAYS INVOLVING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS
#6705APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof
#6706Novel Rationally Designed Protein Compositions
#6707METHOD OF TREATING A LOCALIZED FIBROTIC DISORDER USING A TNF RECEPTOR 2 ANTAGONIST
#6708mRNA Vaccine
#6709Engineered IGA antibodies and methods of use
#6710COMBINE HARVESTER CONCAVE THRESHING BAR
#6711RECOMBINANT BIFUNCTIONAL PROTEIN TARGETING CD47 AND HER2
#6712ANTI-DLL3 ANTIBODY
#6713Anti-mesothelin binding proteins
#6714Targeting metastasis stem cells through a fatty acid receptor (CD36)
#6715A NOVEL ANTI-CD3/ANTI-CD20 BISPECIFIC ANTIBODY
#6716Anti-CD137 antibodies and method of treating colorectal cancer using them
#6717METHODS FOR TREATING SEVERE ASTHMA IN PATIENTS WITH NASAL POLYPOSIS
#6718METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST
#6719HUMAN ANTIBODIES TO PD-L1
#6720DE-ADCC/CDC FUNCTIONS OF ANTIBODIES AND THEIR APPLICATIONS
#6721Anti-PD-L1 antibodies
#6722Anti-PD-L1 antibody and use thereof
#6723VISTA ANTIGEN-BINDING MOLECULES
#6724Anti-PD-1 antibodies
#6725METHODS OF TREATING TUMOR
#6726Costimulatory B7-H1 in renal cell carcinoma patients: indicator of tumor aggressiveness and potential therapeutic target
#6727Methods for achieving therapeutically effective doses of anti-CD47 agents
#6728ANTIBODIES FOR TREATING MALIGNANT TUMORS AND USES THEREOF
#6729MODULATION OF IRF-4 AND USES THEREOF
#6730MULTIFUNCTIONAL MOLECULES THAT BIND TO T CELL RELATED CANCER CELLS AND USES THEREOF
#6731ANTI-CLAUDIN ANTIBODIES AND USES THEREOF
#6732DLL3 SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC COMPOSITIONS THEREOF
#6733Compositions And Methods For Treating Cancer
#6734COMPOSITIONS TARGETING THE SOLUBLE EXTRACELLULAR DOMAIN OF E-CADHERIN AND RELATED METHODS FOR CANCER THERAPY
#6735MULTIFUNCTIONAL MOLECULES THAT BIND TO CALRETICULIN AND USES THEREOF
#6736METHODS FOR TREATING NEUROBLASTOMA
#6737METHODS FOR ASSESSING RISK OF DEVELOPING A VIRAL DISEASE USING A GENETIC TEST
#6738BIOLOGICAL PRODUCTS
#6739Antibodies to ticagrelor and methods of use
#6740Chimeric antigen receptors targeting glypican-3 or mesothelin
#6741CONJUGATED ANTIBOIDES AGAINST LY75 FOR THE TREATMENT OF CANCER
#6742BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20
#6743ANTI-TNFR2 ANTIBODIES AND USES THEREOF
#6744PDGF receptor antibody and use thereof
#6745Modulators of ROR1-ROR2 binding
#6746Recombinant Fusion Proteins Targeting P-selectin, and Methods of Use Thereof for Treating Diseases and Disorders
#6747Methods of treating inflammatory diseases by blocking Galectin-3
#6748ANTIGEN BINDING CONSTRUCTS TO CD4
#6749HOMODIMERIC BISPECIFIC ANTIBODY, PREPARATION METHOD THEREFOR AND USE THEREOF
#6750Anti-CD45 antibodies and conjugates thereof
#6751CD47 ANTIBODIES AND METHODS OF USE THEREOF
#6752Anti-CD200R1 antibodies and methods of use thereof
#6753Immunocytes expressing a chimeric antigen receptor binding to cancer cells and TNF-related apoptosis-inducing ligand (trail)
#6754Materials and methods for treating stress-related disorders and cancer
#6755Compounds
#6756Use of IL-1 beta Binding Antibodies
#6757ANTI-N3pGlu AMYLOID BETA PEPTIDE ANTIBODIES AND USES THEREOF
#6758NMES1 ANTIBODIES AND METHODS OF USE THEREOF
#6759Anti-transthyretin antibodies
#6760ANTI-ABETA ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND APPLICATION THEREOF
#6761Human antibodies to influenza hemagglutinin
#6762Circular RNA compositions and methods
#6763Compositions and methods for the depletion of CD5+ cells
#6764ANTIBODY FORMULATION
#6765ANTI-RSPO3 ANTIBODIES AND METHODS OF USE
#6766CLOSTRIDIUM DIFFICILE ANTIGENS
#6767Combination of vaccination and OX40 agonists
#6768Compositions and methods for treating central nervous system injury
#6769Hematopoietic stem cell engraftment
#6770Depleting tumor-specific tregs
#6771Methods, compositions and kits for treating a subject using a recombinant heteromultimeric neutralizing binding protein
#6772Anti-DCLK1 antibodies and chimeric antigen receptors, and compositions and methods of use thereof
#6773ANTI-HER2 COMBINATIONS FOR TREATING TUMORS
#6774Antibodies against signal-regulatory protein alpha and methods of use
#6775Antibodies That Bind CD39 and Uses Thereof
#6776ANTI-4-1BB ANTIBODY, ANTIGEN-BINDING FRAGMENT THEREOF AND MEDICAL USE THEREOF
#6777MYOSTATIN, ACTIVIN OR ACTIVIN RECEPTOR ANTAGONISTS FOR USE IN TREATING OBESITY AND RELATED CONDITIONS
#6778ANTIBODY SPECIFICALLY BINDING TO C-MET, AND USE THEREOF
#6779NOVEL FUSION PROTEIN SPECIFIC FOR CD137 AND PD-L1
#6780METHODS AND COMPOSITIONS FOR BLOCKING INTERACTION BETWEEN NON-GLYCOSYLATED PD-1 POLYPEPTIDES
#6781PHARMACEUTICAL COMBINATIONS
#6782T CELL RECRUITING POLYPEPTIDES BASED ON CD3 REACTIVITY
#6783Compound that specifically binds to KIR3DL2 for use in the treatment of peripheral T cell lymphoma
#6784Fusion proteins comprising extracellular domain of human CD22
#6785CD226 agonist antibodies
#6786Compositions and methods for modulating LAIR signal transduction
#6787Anti-IL-33 antibodies and uses thereof
#6788Safe and Effective Method of Treating Psoriatic Arthritis with Anti-IL23 Specific Antibody
#6789Method of treating inflammatory bowel disease with a combination therapy of antibodies to IL-23 and TNF alpha
#6790TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IL-12/IL-23 INHIBITOR
#6791Antibodies to IL-34
#6792HIGH DOSE TREATMENTS FOR ALZHEIMER'S DISEASE
#6793POLY-N-ACETYL GLUCOSAMINE (PNAG/DPNAG)-BINDING PEPTIDES AND METHODS OF USE THEREOF
#6794NOVEL ANTIBODIES SPECIFICALLY BINDING TO ZIKA VIRUS EPITOPES AND USES THEREOF
#6795APRIL and BAFF inhibitory immunomodulatory proteins and methods of use thereof
#6796Glypican 3 antibodies and conjugates thereof
#6797CANCER IMMUNOTHERAPY USING VIRUS PARTICLES AND IMMUNE CHECKPOINT THERAPY
#6798Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof
#6799COMBINATION THERAPY WITH GLUTAMINASE INHIBITORS AND IMMUNO-ONCOLOGY AGENTS
#6800TRANSDERMAL SYSTEM FOR SYNERGISTIC IMMUNE-CHEMOTHERAPY USING MICRONEEDLES AND METHOD OF TREATMENT THEREOF
#6801Nidogen 1 as a diagnostic marker and therapeutic target of hepatocellular carcinoma, composition and methods thereof
#6802METHODS FOR INHIBITING FIBROSIS IN A SUBJECT IN NEED THEREOF
#6803Compositions and Methods For Treating Cancer with Anti-Renalase antibodies and Anti-PD1 antibodies
#6804BISPECIFIC T CELL ACTIVATING ANTIGEN BINDING MOLECULES
#6805Bispecific anti-CD37 antibodies, monoclonal anti-CD37 antibodies and methods of use thereof
#6806Anti-OX40 antibody, antigen-binding fragment thereof, and the pharmaceutical use
#6807Fc binding fragments comprising an OX40 antigen-binding site
#6808Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)
#6809Humanized anti-human-PD-1 antibody and its use in cancer treatment
#6810Targeting the Non-Canonical NFkB Pathway in Cancer Immunotherapy
#6811ANTIBODIES SPECIFIC TO CTLA-4 AND USES THEREOF
#6812CONDITIONALLY ACTIVATED TARGET-BINDING MOLECULES
#6813METHODS AND SYSTEMS FOR CONTROLLING THE AGONISTIC PROPERTIES OF ANTIBODY VARIABLE DOMAINS BY LIGHT
#6814TREATMENT OF T CELL LYMPHOMA
#6815Anti-C-KIT antibody
#6816MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#6817Methods and kits for diagnosing and/or treating peripheral neuropathy
#6818COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING EPO
#6819Anti-IL-5 Antibodies
#6820Antibodies that bind transforming growth factor beta (TGF beta) and methods of use thereof for treatment
#6821Antibody binding active α-synuclein
#6822Anti-tenascin C antibodies and uses thereof
#6823Antibody Molecules and Peptide Delivery Systems for Use in Alzheimer's Disease and Related Disorders
#6824Antibodies specifically binding to Zika virus epitopes and uses thereof
#6825Variant nucleic acid libraries for coronavirus
#6826Targeted IL-12 heterodimeric Fc-fusion proteins
#6827TARGETED LIPID PARTICLES AND COMPOSITIONS AND USES THEREOF
#6828INDUCED STEM MEMORY T CELLS AND METHODS OF USE THEREOF
#6829METHODS OF REVERSING TICAGRELOR ACTIVITY
#6830Masked chimeric antigen receptor specific to tyrosine-protein kinase like 7 (PTK7) and immune cells expressing such
#6831ANTI-HER2 COMBINATIONS FOR TREATING TUMORS
#6832Mesothelin-targeted CD40 agonistic multispecific antibody constructs for the treatment of solid tumors
#6833ANTIBODIES AGAINST TL1A AND USES THEREOF
#6834BINDING AGONIST FOR TREATMENT OF NEUROLOGICAL AND OTHER DISORDERS
#6835ANTI-B7H3 ANTIBODY-EXATECAN ANALOG CONJUGATE AND MEDICINAL USE THEREOF
#6836ROR2 antibody compositions and related methods
#6837Engineered antibody Fc variants for enhanced serum half life
#6838COMPOSITIONS AND METHODS FOR MODULATING AN IMMUNE RESPONSE
#6839MATRIX METALLOPROTEASE-CLEAVABLE AND SERINE PROTEASE-CLEAVABLE SUBSTRATES AND METHODS OF USE THEREOF
#6840COMPOSITIONS AND METHODS FOR TREATING ISCHEMIC HEART DISEASE
#6841ANTI-GM-CSF ANTIBODIES
#6842MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFalpha-RELATED DISORDERS
#6843MULTIPLE-VARIABLE DOSE REGIMEN FOR TREATING TNFALPHA-RELATED DISORDERS
#6844USE OF ANTI-FAM19A5 ANTIBODIES
#6845Compounds and methods for treating pain
#6846HUMANISED ANTI-N-TRUNCATED AMYLOID BETA MONOCLONAL ANTIBODY
#6847ANTIBODIES SPECIFIC FOR HUMAN AND CYNOMOLGUS APOC3 AND METHODS OF USE THEREOF
#6848Human zika virus antibodies and methods of use therefor
#6849Fc-epsilon car
#6850Immunostimulatory agents in combination with angiogenesis inhibitors
#6851LY75 AS CANCER THERAPEUTIC AND DIAGNOSTIC TARGET
#6852IMMUNOCONJUGATES WITH AN INTRACELLULARLY-CLEAVABLE LINKAGE
#6853ANTI-HER2 BIPARATOPIC ANTIBODY-DRUG CONJUGATES AND METHODS OF USE
#6854COMBINATION CELL-BASED THERAPIES
#6855COMBINATION IMMUNOTHERAPIES
#6856FUSION POLYPEPTIDE COMPRISING POLYPEPTIDE REGION THAT CAN BE O-GLYCOSYLATED
#6857COMPOSITIONS AND METHODS FOR ENHANCING DONOR OLIGONUCLEOTIDE-BASED GENE EDITING
#6858METHODS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF MUCOSAL INFLAMMATORY DISEASES
#6859ESOPHAGEAL CANCER MARKER AND USE THEREOF
#6860Targeting CLPTM1L for treatment and prevention of cancer
#6861Anti-mesothelin constructs and uses thereof
#6862Anti-Jagged1 antigen binding proteins
#6863Anti-GITR antibodies and uses thereof
#6864Therapeutic antibody fragments, methods of making, and methods of use
#6865Anti-Follicule Stimulating Hormone Receptor Antibodies
#6866DUAL RECEPTOR ANTAGONISTIC ANTIGEN-BINDING PROTEINS AND USES THEREOF
#6867Treatment with anti-α4β7 antibody
#6868ANTIBODIES TO INTEGRIN AVB6 AND USE OF SAME TO TREAT CANCER
#6869Affibody proteins specific for B7-H3 (CD276)
#6870Gene Signatures for Determining ICOS Expression
#6871Humanized antibodies with increased stability
#6872PAN-ELR+ CXC chemokine antibodies for the treatment of hidradenitis suppurativa
#6873ANTI-PD-1/VEGFA BIFUNCTIONAL ANTIBODY, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF
#6874METHOD FOR INHIBITING BONE RESORPTION
#6875MONOCLONAL ANTIBODIES AGAINST HUMAN DICKKOPF3 AND USES THEREOF
#6876METHODS OF TREATING AND PREVENTING STAPHYLOCOCCUS AUREUS INFECTIONS AND ASSOCIATED CONDITIONS
#6877CHIMERIC RECEPTOR POLYPEPTIDES IN COMBINATION WITH TRANS METABOLISM MOLECULES MODULATING INTRACELLULAR LACTATE CONCENTRATIONS AND THERAPEUTIC USES THEREOF
#6878Granulysin, method of obtaining same, and uses
#6879COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY
#6880MULTI-SPECIFIC BINDING CONJUGATE, RELATED PHARMACEUTICAL COMPOSITIONS AND USE
#6881Long Acting Multi-Specific Molecules And Related Methods
#6882ANTI-SEZ6 ANTIBODY DRUG CONJUGATES AND METHODS OF USE
#6883Combination Therapy of Immunotoxin and Checkpoint Inhibitor
#6884Method of treating autoimmune inflammatory crohn's disease
#6885METHODS OF TREATING MULTIPLE MYELOMA
#6886ONCOLYTIC ADENOVIRUS ENCODING A B7 PROTEIN
#6887DNA HYPOMETHYLATING AGENTS FOR CANCER THERAPY
#6888Antigen-binding polypeptides directed against CD38
#6889DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) IN PEDIATRIC PATIENTS
#6890Anti-CD20 glycoantibodies and uses thereof
#6891Methods of reducing or lowering blood glucose levels in a human subject by administering an antibody that specifically binds human glucagon receptor
#6892Tie2-binding agents and methods of use
#6893Galectin-10 antibodies
#6894MODULATION OF LEUKOCYTE ACTIVITY IN TREATMENT OF NEUROINFLAMMATORY DEGENERATIVE DISEASE
#6895METHODS FOR DIAGNOSING AND TREATING CANCERS
#6896Bispecific antibody
#6897Heavy chain antibodies binding to CD19
#6898BI-SPECIFIC ANTIBODIES AGAINST TIM-3 AND PD-1 FOR IMMUNOTHERAPY IN CHRONIC IMMUNE CONDITIONS
#6899ANTI-IL-6 ANTIBODIES FOR THE TREATMENT OF ORAL MUCOSITIS
#6900Anti-IL-25 antibodies and use thereof